Lv3
248 积分 2023-06-07 加入
Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates
10天前
已完结
Expression status of PD-L1 and B7-H3 in mesothelioma
3个月前
已完结
Tumor vascular normalization by B7-H3 blockade augments T lymphocyte-mediated antitumor immunity
3个月前
已完结
Combining antibody-drug conjugates with immune checkpoint inhibitors: A new paradigm for breast cancer therapy
4个月前
已完结
Targeting PD-1/PD-L1 in tumor immunotherapy: Mechanisms and interactions with host growth regulatory pathways
4个月前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
5个月前
已完结
皖公网安备34019202002308
